OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
032830$249500.0058

Samsung Life Insurance Co Ltd

Life & Health InsuranceVerified

Samsung Life Insurance maintains a liquidity position with a price-to-book ratio of 0.71 and a debt-to-equity ratio of 0.37, indicating a moderate leverage profile. The company's free cash flow of 1.695 trillion KRW supports operational flexibility, though its net cash position is negative after subtracting total debt. Profitability metrics show a return on equity of 3.67% and a return on assets of 0.66%, both below the typical thresholds for insurance firms. The price-to-earnings ratio of 19.46 suggests the market is valuing the company at a premium relative to its earnings, but this is tempered by the low tangible book value. The company's revenue is concentrated in its core insurance business, with no disclosed geographic diversification beyond South Korea. This lack of geographic spread increases exposure to local economic and regulatory risks. Samsung Life Insurance's outlook for the current fiscal year shows a stable revenue trajectory, with no significant growth or contraction expected. The company's operating income of 1.797 trillion KRW and net income of 2.303 trillion KRW reflect a consistent performance, though growth is not anticipated in the near term. The risk assessment highlights medium liquidity risk and low dilution potential. However, the negative net cash position after subtracting total debt is a key flag. The company has not disclosed any recent dilutive events, and the dilution probability is assessed as low. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's capital structure and operational performance remain stable, with no significant changes in its business model or risk profile.

30-day price · 032830+116500.00 (+48.8%)
Low$224000.00High$359000.00Close$355000.00As of22 May, 00:00 UTC
Profile
CompanySamsung Life Insurance Co Ltd
Ticker032830.KS
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Samsung Life Insurance Co Ltd is a Korea-based company that provides life insurance, health insurance, critical illness insurance, pension insurance, and savings insurance, generating revenue primarily through premium income and investment returns.

Classification. Samsung Life Insurance is classified under the Financials sector, Insurance business sector, and Life & Health Insurance industry with a confidence level of 0.92.

Samsung Life Insurance maintains a liquidity position with a price-to-book ratio of 0.71 and a debt-to-equity ratio of 0.37, indicating a moderate leverage profile. The company's free cash flow of 1.695 trillion KRW supports operational flexibility, though its net cash position is negative after subtracting total debt. Profitability metrics show a return on equity of 3.67% and a return on assets of 0.66%, both below the typical thresholds for insurance firms. The price-to-earnings ratio of 19.46 suggests the market is valuing the company at a premium relative to its earnings, but this is tempered by the low tangible book value. The company's revenue is concentrated in its core insurance business, with no disclosed geographic diversification beyond South Korea. This lack of geographic spread increases exposure to local economic and regulatory risks. Samsung Life Insurance's outlook for the current fiscal year shows a stable revenue trajectory, with no significant growth or contraction expected. The company's operating income of 1.797 trillion KRW and net income of 2.303 trillion KRW reflect a consistent performance, though growth is not anticipated in the near term. The risk assessment highlights medium liquidity risk and low dilution potential. However, the negative net cash position after subtracting total debt is a key flag. The company has not disclosed any recent dilutive events, and the dilution probability is assessed as low. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's capital structure and operational performance remain stable, with no significant changes in its business model or risk profile.
Key takeaways
  • Samsung Life Insurance has a moderate leverage profile with a debt-to-equity ratio of 0.37.
  • The company's return on equity of 3.67% is below the typical thresholds for insurance firms.
  • The price-to-book ratio of 0.71 suggests the company is undervalued relative to its book value.
  • The company's revenue is concentrated in its core insurance business with no geographic diversification.
  • Analysts have a mixed outlook, with a mean recommendation of 2.26 and a mean price target of 240,430.77 KRW.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue
Gross profit
Operating income$1.80T
Net income$2.30T
R&D
SG&A
D&A
SBC
Operating cash flow$5.26T
CapEx-$169.64B
Free cash flow$1.70T
Total assets$350.69T
Total liabilities$287.96T
Total equity$62.72T
Cash & equivalents$4.54T
Long-term debt$23.45T
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.80T$2.30T$1.70T
FY-1-$1.81T$2.11T$1.68T
FY-2$1.45T$1.90T$1.56T
FY-3$678.60B$2.17T$1.90T
FY-4$385.68B$1.47T$1.34T
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$350.69T$62.72T$4.54T
FY-1$312.22T$36.10T$4.18T
FY-2$314.66T$42.44T$5.49T
FY-3$296.23T$39.68T$8.86T
FY-4$341.38T$37.81T$4.38T
PeriodOCFCapExFCFSBC
FY0$5.26T-$169.64B$1.70T
FY-1$5.00T-$116.14B$1.68T
FY-2$1.47T-$129.09B$1.56T
FY-3$880.72B-$134.81B$1.90T
FY-4$2.55T-$100.98B$1.34T
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0-$1.07T$185.70B$228.61B
FQ-1-$651.66B$722.99B$799.73B
FQ-2$3.28T$758.89B$829.83B
FQ-3$242.64B$635.26B$710.94B
FQ-4-$3.35T$64.69B$98.01B
FQ-5$2.20T$673.61B$749.70B
FQ-6-$201.33B$746.44B$846.47B
FQ-7-$456.73B$622.09B$712.08B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$350.69T$62.72T$4.54T
FQ-1$335.31T$38.85T$3.66T
FQ-2$319.12T$31.64T$3.68T
FQ-3$318.86T$29.51T$3.67T
FQ-4$312.22T$36.10T$4.18T
FQ-5$312.67T$33.32T$4.12T
FQ-6$319.80T$39.59T$4.02T
FQ-7$315.77T$41.51T$3.63T
PeriodOCFCapExFCFSBC
FQ0$5.26T-$169.64B$228.61B
FQ-1$3.94T-$102.81B$799.73B
FQ-2$2.51T-$69.83B$829.83B
FQ-3$144.39B-$33.62B$710.94B
FQ-4$5.00T-$116.14B$98.01B
FQ-5$5.90T-$68.89B$749.70B
FQ-6$3.31T-$33.79B$846.47B
FQ-7$1.25T-$21.17B$712.08B
Valuation
Market price$249500.00
Market cap$44.80T
Enterprise value$63.72T
P/E19.5
Reported non-GAAP P/E
EV/Revenue
EV/Op income35.5
EV/OCF12.1
P/B0.7
P/Tangible book0.7
Tangible book$62.72T
Net cash-$18.91T
Current ratio
Debt/Equity0.4
ROA0.7%
ROE3.7%
Cash conversion2.3%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
Metric032830Activity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity37.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Observations
IR observations
Mean price target240,430.77 KRW
Median price target253,000.00 KRW
High price target307,000.00 KRW
Low price target170,000.00 KRW
Mean recommendation2.26 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count8.00
Hold count8.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate13,455.16 KRW
Last actual EPS12,824.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 06:57 UTC#e61ddd57
Market quoteclose KRW 249500.00 · shares 0.18B diluted
no public URL
2026-05-01 06:57 UTC#27778997
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 06:58 UTCJob: 59f63495